EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Disseminated Intravascular Coagulation Following Idarucizumab and Andexanet Alfa: Assessment of a Signal of Disproportionate Reporting From the Food and Drugs Administration Adverse Event Reporting System (FAERS) Database

Giuseppe Roberto, Lorenzo Parmeggiani, Alessandra Flaccavento, Alfredo Vannacci, Guido Mannaioni, Rosa Gini, Gianni Virgili, Marco Tuccori

Drug Safety · 2026-06 · 49 (6) · 689-704

DOI: 10.1007/s40264-026-01648-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Safety, online erschienen am 22.03.2026. Verfasst von Giuseppe Roberto und 7 weiteren Autor:innen. Beteiligte Einrichtung: Università degli Studi di Firenze, Scuola diScienze della Salute Umana, Largo Brambilla, 50134, Florence, Italy. giuseppe.roberto@ars.toscana.it. Hauptthemen laut MEDLINE: Adverse Drug Reaction Reporting Systems, Antibodies, Monoclonal, Humanized, Factor Xa, Disseminated Intravascular Coagulation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Università degli Studi di Firenze.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adverse Drug Reaction Reporting SystemsAntibodies, Monoclonal, HumanizedFactor XaDisseminated Intravascular CoagulationHumansUnited States Food and Drug AdministrationUnited StatesDatabases, FactualRecombinant Proteins

Substanzen

Antibodies, Monoclonal, HumanizedidarucizumabFactor XaRecombinant ProteinsPRT064445

Autor:innen und Institutionen

  • Università degli Studi di Firenze, Scuola diScienze della Salute Umana, Largo Brambilla, 50134, Florence, Italy. giuseppe.roberto@ars.toscana.it.
  • Department of Emergency Medicine, Careggi University Hospital, Firenze, Italy.
  • Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
  • Department of Neurosciences, Psychology, Drug Research and Child Health, NEUROFARBA, University of Florence, Florence, Italy.
  • Tuscan Regional Centre of Pharmacovigilance, Florence, Italy.
  • Azienda Ospedaliera Universitaria di Careggi, Clinical Toxicology and Poison Control Centre, Firenze, Italy.

Förderung

  • Università degli Studi di Firenze

Zitieren

APA

Roberto, G., Parmeggiani, L., Flaccavento, A., Vannacci, A., Mannaioni, G., Gini, R., Virgili, G., & Tuccori, M. (2026). Disseminated Intravascular Coagulation Following Idarucizumab and Andexanet Alfa: Assessment of a Signal of Disproportionate Reporting From the Food and Drugs Administration Adverse Event Reporting System (FAERS) Database. Drug Safety, 49(6), 689-704. https://doi.org/10.1007/s40264-026-01648-8

Vancouver

Roberto G, Parmeggiani L, Flaccavento A, Vannacci A, Mannaioni G, Gini R, et al. Disseminated Intravascular Coagulation Following Idarucizumab and Andexanet Alfa: Assessment of a Signal of Disproportionate Reporting From the Food and Drugs Administration Adverse Event Reporting System (FAERS) Database. Drug Safety. 2026;49(6):689-704. doi:10.1007/s40264-026-01648-8

BibTeX
@article{Roberto2026,
  author = {Roberto, Giuseppe and Parmeggiani, Lorenzo and Flaccavento, Alessandra and Vannacci, Alfredo and Mannaioni, Guido and Gini, Rosa and Virgili, Gianni and Tuccori, Marco},
  title = {Disseminated Intravascular Coagulation Following Idarucizumab and Andexanet Alfa: Assessment of a Signal of Disproportionate Reporting From the Food and Drugs Administration Adverse Event Reporting System (FAERS) Database},
  journal = {Drug Safety},
  year = {2026},
  volume = {49},
  number = {6},
  pages = {689--704},
  doi = {10.1007/s40264-026-01648-8}
}
Kostenlos starten →